Immune repertoire diversity correlated with mortality in Avian Influenza A (H7N9) virus infected patients

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hou, Dongni ^a   Ying, Tianlei ^a   Wang, Lili ^a   Chen, Cuicui ^a   Lu, Shuihua ^a   Wang, Qin ^a   Seeley, Eric ^b   Xu, Jianqing ^a   Xi, Xiuhong ^a   Li, Tao ^a   Liu, Jie ^a   Tang, Xinjun ^a   Zhang, Zhiyong ^a   Zhou, Jian ^a   Bai, Chunxue ^a   Wang, Chunlin ^c   Byrne Steele, Miranda ^c   Qu, Jieming ^d   Han, Jian ^c   Song, Yuanlin ^a,e  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988872457     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep33843     Document Type: Article

References (36)

1. WHO. Assessment WR. Summary of Surveillance and Investigation findings-Human Cases of Avian Influenza A (H7N9) Virus Infection to Date, http://www.who.int/influenza/human-animal-interface/influenza-h7n9/riskassessment-h7n9-2Oct14.pdf (2014
2. Gao H. N., et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. The New England journal of medicine 368, 2277-2285, doi: 10.1056/NEJMoa1305584 (2013
3. Yu L., et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 57, 1449-1457, doi: 10.1093/cid/cit541 (2013
4. Lu S., et al. Prognosis of 18 H7N9 avian influenza patients in Shanghai. PloS one 9, e88728, doi: 10.1371/journal.pone.0088728 (2014
5. Quinones-Parra S., et al. Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities. Proceedings of the National Academy of Sciences of the United States of America 111, 1049-1054, doi: 10.1073/pnas.1322229111 (2014
6. De Groot A. S., et al. Low immunogenicity predicted for emerging avian-origin H7N9: implication for influenza vaccine design. Human vaccines, & immunotherapeutics 9, 950-956, doi: 10.4161/hv.24939 (2013
7. Van De Sandt C. E., et al. Human cytotoxic T lymphocytes directed to seasonal influenza A viruses cross-react with the newly emerging H7N9 virus. Journal of virology 88, 1684-1693, doi: 10.1128/JVI.02843-13 (2014
8. Wang Z., et al. Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8(+ ) T cells. Nature communications 6, 6833, doi: 10.1038/ncomms7833 (2015
9. Woodsworth D. J., Castellarin M., & Holt R. A. Sequence analysis of T-cell repertoires in health and disease. Genome medicine 5, 98, doi: 10.1186/gm502 (2013
10. Georgiou G., et al. The promise and challenge of high-throughput sequencing of the antibody repertoire. Nature biotechnology 32, 158-168, doi: 10.1038/nbt.2782 (2014
11. Calis J. J., & Rosenberg B. R. Characterizing immune repertoires by high throughput sequencing: strategies and applications. Trends in immunology 35, 581-590, doi: 10.1016/j.it.2014.09.004 (2014
12. DeKosky B. J., et al. High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire. Nature biotechnology 31, 166-169, doi: 10.1038/nbt.2492 (2013
13. Vollmers C., Sit R. V., Weinstein J. A., Dekker C. L., & Quake S. R. Genetic measurement of memory B-cell recall using antibody repertoire sequencing. Proceedings of the National Academy of Sciences of the United States of America 110, 13463-13468, doi: 10.1073/pnas.1312146110 (2013
14. Jiang N., et al. Lineage structure of the human antibody repertoire in response to influenza vaccination. Science translational medicine 5, 171ra119, doi: 10.1126/scitranslmed.3004794 (2013
15. Gearhart P. J. Immunology: the roots of antibody diversity. Nature 419, 29-31, doi: 10.1038/419029a (2002
16. Zhang A., et al. Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013. Euro surveillance: bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 18, 20657 (2013
17. Laserson U., et al. High-resolution antibody dynamics of vaccine-induced immune responses. Proceedings of the National Academy of Sciences of the United States of America 111, 4928-4933, doi: 10.1073/pnas.1323862111 (2014
18. Hughes M. M., et al. T cell receptor CDR3 loop length repertoire is determined primarily by features of the V(D)J recombination reaction. European journal of immunology 33 1568-1575 10.1002/eji.200323961 2003
19. Davis M. M., et al. Ligand recognition by alpha beta T cell receptors. Annual review of immunology 16, 523-544, doi: 10.1146/annurev.immunol.16.1.523 (1998
20. Jackson K. J., et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell host, & microbe 16, 105-114, doi: 10.1016/j.chom.2014.05.013 (2014
21. Pappas L., et al. Rapid development of broadly influenza neutralizing antibodies through redundant mutations. Nature 516, 418-422, doi: 10.1038/nature13764 (2014
22. Chen Z., et al. Human monoclonal antibodies targeting the haemagglutinin glycoprotein can neutralize H7N9 influenza virus. Nature communications 6, 6714, doi: 10.1038/ncomms7714 (2015
23. Galson J. D., Pollard A. J., Truck J., & Kelly D. F. Studying the antibody repertoire after vaccination: practical applications. Trends in immunology 35, 319-331, doi: 10.1016/j.it.2014.04.005 (2014
24. Robinson W. H. Sequencing the functional antibody repertoire-diagnostic and therapeutic discovery. Nature reviews. Rheumatology
25. Goronzy J. J., & Weyand C. M. T cell development and receptor diversity during aging. Current opinion in immunology 17 468-475 10.1016/j.coi.2005.07.020 2005
26. Jenkins M. R., Kedzierska K., Doherty P. C., & Turner S. J. Heterogeneity of effector phenotype for acute phase and memory influenza A virus-specific CTL. Journal of immunology 179, 64-70 (2007
27. La Gruta N. L., et al. Epitope-specific TCRbeta repertoire diversity imparts no functional advantage on the CD8+ T cell response to cognate viral peptides. Proceedings of the National Academy of Sciences of the United States of America 105, 2034-2039, doi: 10.1073/pnas.0711682102 (2008
28. Hillen K. M., et al. T cell expansion is the limiting factor of virus control in mice with attenuated TCR signaling: implications for human immunodeficiency. Journal of immunology 194 2725-2734 10.4049/jimmunol.1400328 2015
29. Marchingo J. M., et al. T cell signaling. Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansion. Science 346, 1123-1127, doi: 10.1126/science.1260044 (2014
30. Warren R. L., et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome research 21, 790-797, doi: 10.1101/gr.115428.110 (2011
31. Robins H. S., et al. Overlap and effective size of the human CD8+ T cell receptor repertoire. Science translational medicine 2, 47ra64, doi: 10.1126/scitranslmed.3001442 (2010
32. Corti D., et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850-856, doi: 10.1126/science.1205669 2011
33. Ekiert D. C., et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246-251, doi: 10.1126/science.1171491 (2009
34. Ekiert D. C., et al. A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843-850, doi: 10.1126/science.1204839 2011
35. Qiu C., et al. Safe pseudovirus-based assay for neutralization antibodies against influenza A(H7N9) virus. Emerging infectious diseases 19, 1685-1687, doi: 10.3201/eid1910.130728 (2013
36. Wang C., et al. High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proceedings of the National Academy of Sciences of the United States of America 107, 1518-1523, doi: 10.1073/pnas.0913939107 (2010